货号:A200225
同义名:
二甲氧基雌二醇
/ 2-ME2; NSC-659853
2-Methoxyestradiol是雌激素的天然代谢物,已知能够抑制HIF-1α,IC50为0.71 ± 0.11 μM,抑制BPAEC迁移。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | HIF ↓ ↑ | HIF1 ↓ ↑ | PHD1 ↓ ↑ | PHD2 ↓ ↑ | PHD3 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KC7F2 |
+
HIF-1α, IC50: 20 μM |
+
HIF-1α, IC50: 20 μM |
98% | ||||||||||||||||
| Roxadustat | ✔ | 98+% | |||||||||||||||||
| Lificiguat | ✔ | 99%+ | |||||||||||||||||
| BAY 87-2243 | ✔ | 99%+ | |||||||||||||||||
| PX-478·2HCl | ✔ | 98%+ | |||||||||||||||||
| 2-Methoxyestradiol | ✔ | 98% | |||||||||||||||||
| LW6 |
++
HIF, IC50: 4.4 μM |
BCRP | 99%+ | ||||||||||||||||
| Daprodustat | ✔ | 98+% | |||||||||||||||||
| DMOG | ✔ | 98% | |||||||||||||||||
| FG 2216 |
++
PHD2, IC50: 3.9 μM |
99%+ | |||||||||||||||||
| IOX2 |
+++
PHD2, IC50: 21 nM |
99% | |||||||||||||||||
| Molidustat |
++
PHD1, IC50: 480 nM |
+++
PHD2, IC50: 280 nM |
+++
PHD3, IC50: 450 nM |
98+% | |||||||||||||||
| MK-8617 |
++++
PHD1, IC50: 1 nM |
++++
PHD2, IC50: 1 nM |
++++
PHD3, IC50: 14 nM |
99%+ | |||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | The response of mammalian cells to hypoxia is mediated by a family of transcription factors known as HIF (hypoxia-inducible factors). The subunits of HIF, HIF-1α and HIF-2α are structurally similar and can be degraded rapidly under normoxia. 2-Methoxyestradiol can inhibit HIF-1α and HIF-2α expression, as well as depolymerize microtubules. Treatment with 2-Methoxyestradiol (5 - 100 μM) for 16h can reduce expression of HIF-1α dose-dependently in PC-3 and MDA-MB-231 cells, accompanied with the reduced activity of HIF-1 and the expression of its target protein, VEGF, and without effect on HIF-1α mRNA levels or rate of protein degradation. Treatment with 2-Methoxyestradiol (10 - 100 μM) overnight can depolymerize microtubules and impair nuclear accumulation of HIF-1α in PC-3 cells under hypoxia. Daily oral administration of 2-Methoxyestradiol, 150 mg/kg, for 33 days suppressed tumor growth and angiogenesis, as well as depolymerized microtubules in breast cancer orthotopic models. The inhibition of HIF-2α expression and microtubule-depolymerization by 2-Methoxyestradiol can also be observed in endothelial cells[1]. |
| 作用机制 | 2-Methoxyestradiol inhibits the expression, nuclear accumulation and transcriptional activity of HIF-1α[1]. However, the accurate mechanism of action is unknown now. |
| Concentration | Treated Time | Description | References | |
| metastatic osteosarcoma 143B cells | 1 nM | 8 h | To compare the effects of physiological (1 nM) and pharmacological (1 μM) concentrations of 2-ME on•NO2 generation, results showed significant increase in•NO2 levels even at physiological concentration. | Redox Biol. 2020 May;32:101522. |
| metastatic osteosarcoma 143B cells | 1 μM | 2 h | To investigate the effect of 2-ME on the generation of reactive nitrogen species (RNS) in 143B cells, results showed peak NO release at 2 h and peak ONOO− release at 8 h post-treatment. | Redox Biol. 2020 May;32:101522. |
| primary cortical cultures (PCCs) | 10 μM | 16 h | inhibited HIF-1α activation and nuclear translocation, preventing hypoxia-mediated STI-1 production | EMBO Mol Med. 2013 Aug;5(8):1227-46. |
| A549 cells (3D spheroid model) | 0.78 μM–200 μM | 48 h | To evaluate the effect of 2-methoxyestradiol on the viability of 3D spheroid A549 cells, results showed that 2-methoxyestradiol significantly reduced the viability of 3D spheroid A549 cells in a dose-dependent manner. | Redox Biol. 2022 Sep;55:102395. |
| A549 cells(2D spheroid model) | 0.78 μM–100 μM | 24 h | To evaluate the effect of 2-methoxyestradiol on the viability of A549 cells, results showed that 2-methoxyestradiol significantly reduced the viability of A549 cells in a dose-dependent manner. | Redox Biol. 2022 Sep;55:102395. |
| LNCaP cells | 3µM | 2 h | 2-ME 2 significantly reduced FLIP expression. | Clin Cancer Res. 2009 Mar 1;15(5):1601-11. |
| PC-3 cells | 3µM | 2 h | 2-ME 2 reduced the levels and promoter activity of FLIP (p=0.001), decreased FLIP binding to Fas or FADD, increased cleavage of caspase-8 and Bid, and induced apoptosis. | Clin Cancer Res. 2009 Mar 1;15(5):1601-11. |
| SH-SY5Y cells | 1, 2.5, 4, 5 μM | 48 or 72 h, or 1 to 8 days | 2-ME significantly inhibited the proliferation of SH-SY5Y cells and induced apoptosis. | Cancer Lett. 2011 Dec 27;313(2):201-10. |
| SK-N-SH cells | 1, 2.5, 4, 5 μM | 48 or 72 h, or 1 to 8 days | 2-ME significantly inhibited the proliferation of SK-N-SH cells and induced apoptosis. DNA fragmentation and chromatin condensation were observed in the cells treated with 4 μM 2-ME for 72 h. | Cancer Lett. 2011 Dec 27;313(2):201-10. |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 J male mice | Osteoporosis model | Gavage | 75 mg/kg | Once daily for 4 weeks | To study the improvement of bone-vessel metabolism in aged mice and the damage in young mice by 2-Methoxyestradiol | Stem Cell Res Ther. 2022 Feb 5;13(1):59 |
| Mice | Lumbar spine instability (LSI) surgery model | Intraperitoneal injection | 75 mg/kg | Once daily for 2 or 4 weeks | Evaluated the therapeutic effect of 2ME2 on experimental intervertebral disc degeneration, showing that 2ME2 significantly attenuated LSI surgery-induced disc degeneration, reduced HIF1α expression, and decreased EP cartilage ossification | Bone Res. 2022 Jan 5;10(1):2 |
| Wistar rats | Cyclosporine A-induced nephrotoxicity model | Oral | 5 mg/kg | Once daily for three weeks | To evaluate the protective effects of 2ME-TPGS micelles against cyclosporine A-induced nephrotoxicity. Results showed that 2ME-TPGS significantly ameliorated the deterioration of renal function markers, attenuated pathological changes in kidney tissues, and exhibited significant anti-fibrotic, antioxidant, anti-inflammatory, and anti-apoptotic effects. | Antioxidants (Basel). 2022 Jul 30;11(8):1499 |
| Rats | Cerebral ischemia model | Intraperitoneal injection | 100 mg/kg | Daily for 20 days | Inhibited HIF-1α activity, reducing STI-1 expression post-cerebral ischemia | EMBO Mol Med. 2013 Aug;5(8):1227-46. |
| TRAMP mice | TRAMP prostate cancer model | Oral | 50 mg/kg | 25 weeks | 2-ME 2 intervention led to tumor regression in 90% of the animals, significantly reduced prostate seminal vesicle complex (PSVC) weight (p<0.001), and significantly lowered pathological scores (p<0.001). Tumor regression was associated with reduced expression of FLIP and Sp1. | Clin Cancer Res. 2009 Mar 1;15(5):1601-11. |
| Mice | Cyp1b1−/− and Cyp1b1+/+ mice | Intraperitoneal injection | 1.5 mg/kg | Every 3rd day for 14 days | 2-Methoxyestradiol reduced angiotensin II-induced increases in systolic blood pressure, water consumption, urine output, and proteinuria, and attenuated end-organ damage. | Hypertension. 2017 Jun;69(6):1104-1112 |
| Female mice | CPLA2α+/+/Cyp1b1+/+, cPLA2α−/−/Cyp1b1+/+, and cPLA2α+/+/Cyp1b1−/− | Intraperitoneal injection | 1.5 mg/kg | Every third day for 14 days | 2-Methoxyestradiol ameliorates Ang II-induced hypertension, renal fibrosis, and reactive oxygen species production by inhibiting cPLA2α activity and reducing prostaglandin E2 and thromboxane A2 production. | Hypertension. 2021 Nov;78(5):1368-1381 |
| Dose | Rat: min = 0.1 mg/kg, max = 75 mg/kg[2] (p.o.); min = 60 mg/kg, max = 600 mg/kg[3] (i.p.) | ||||||||||||||
| Administration | p.o., i.p. | ||||||||||||||
| Pharmacokinetics |
|
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.31mL 0.66mL 0.33mL |
16.53mL 3.31mL 1.65mL |
33.07mL 6.61mL 3.31mL |
|
| CAS号 | 362-07-2 |
| 分子式 | C19H26O3 |
| 分子量 | 302.41 |
| SMILES Code | OC(C(OC)=C1)=CC2=C1[C@@]3([H])CC[C@]4(C)[C@@H](O)CC[C@@]4([H])[C@]3([H])CC2 |
| MDL No. | MFCD00010489 |
| 别名 | 二甲氧基雌二醇 ;2-ME2; NSC-659853; Panzem; 2-Hydroxyestradiol 2-methyl ether; 2-MeOE2 |
| 运输 | 蓝冰 |
| InChI Key | CQOQDQWUFQDJMK-SSTWWWIQSA-N |
| Pubchem ID | 66414 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(826.7 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1